MAOIs), and even se ro tonin spe cific re up take in hibi tors (SSRIs) (1). Among newer an ti de pres sants, ven la fax ine has an over all fa vour able side-effect pro file, es pe cially with re spect to switchinducing phe nom ena (2). Short-term effi cacy and ab sence of drug-induced switch has been dem on strated with venla fax ine treat ment of bi po lar de pres sion (3,4). The fol low ing case, how ever, describes a pa tient who de vel oped hy pomanic symp toms on a thera peu tic dos age of ven la fax ine.
(MAOIs), and even se ro tonin spe cific re up take in hibi tors (SSRIs) (1) . Among newer an ti de pres sants, ven la fax ine has an over all fa vour able side-effect pro file, es pe cially with re spect to switchinducing phe nom ena (2) . Short-term effi cacy and ab sence of drug-induced switch has been dem on strated with venla fax ine treat ment of bi po lar de pres sion (3, 4) . The fol low ing case, how ever, describes a pa tient who de vel oped hy pomanic symp toms on a thera peu tic dos age of ven la fax ine.
Mr S, a 35-year-old man, pre sented with a 3-month his tory of ma jor de pres sive epi sode (MDE). He was di ag nosed with bi po lar af fec tive dis or der at age 28 years, and he had suf fered 4 hy po manic epi sodes (of av er age 3 weeks' du ra tion) and 2 de pres sive epi sodes (of av er age 2 months' du ra tion) that re mit ted spon tane ously. Ven la fax ine was ini ti ated at 37.5 mg daily and gradu ally in creased to 150 mg daily over 3 weeks. Al pra zo lam 1.5 mg daily was added to con trol manifest anxi ety. His de pres sive fea tures responded to a mild de gree, while anxi ety less ened. Af ter 1 week at 150 mg daily, how ever, symp toms of over cheer fulness, over talka tive ness, in creased speech rate, in creased en ergy, and decreased sleep sud denly emerged. This was seen ap proxi mately 4 weeks af ter treat ment started. On the fifth day of this symp to matol ogy, ven la fax ine was reduced to 75 mg daily and ta pered off over the sub se quent 2 weeks. Con comitant re duc tion of hy po manic symp toms oc curred in this time frame, fol lowed by their reso lu tion. Ree mer gence of depres sive fea tures 4 days af ter ven la faxine was stopped, how ever, ne ces si tated its re in sti tu tion at 37.5 mg daily, with lith ium pro phy laxis. The pa tient has main tained euthymic status for the last 8 weeks on a regi men of ven la fax ine 37.5 mg daily, al pra zo lam 1.0 mg daily, and lith ium 750 mg daily.
The pa tient de vel oped pos si ble venlafaxine-induced hy po ma nia char acter ized by a switch oc cur ring in the 4-to 8-week time pe riod as so ci ated with an tide pres sant re sponse, by hy po ma nia that was milder and briefer than his spon ta ne ous hy po manic epi sodes, and by re duc tion (fol lowed by dis con tinuation) of ven la fax ine that was as so ci ated with hy po ma nia re mis sion (5) . Ad dition ally, dos age in crease and re duc tion was re lated to hy po ma nia emer gence and reso lu tion, re spec tively. To date, only 1 case of pos si ble venlafaxineinduced ma nia has been re ported (6) . Hence, there is a need to study ven la faxine's role in in duc ing hy po manic switch in pa tients with bi po lar de pres sion, who have an in her ent vul ner abil ity to this phe nome non (1).
Nitin Gupta, MD Chandigarh, India

Discourse Characteristics of Subjects With Schizophrenia and Prominent Negative Symptoms
Dear Edi tor:
Lan guage, which is unique in each subject and con sti tutes a very in di vid ual prod uct, can re flect how a pa tient copes with his dis ease.
In the field of psy chia try, lan guage consti tutes one of the most valu able in ves tiga tive and thera peu tic tools for work ing with pa tients with psy cho sis. A new method of dis course analy sis (Al ceste), based on re cent de vel op ments in data analy sis and com puter tech niques, has con trib uted to a bet ter un der stand ing of the de via tions and ir regu lari ties oc curring in the lan guage of sub jects with psy cho sis (1, 2) . The pre limi nary study pre sented here is part of a 3-step study on lan guage dis tur bances (1-3). It was designed to in ves ti gate the dis course of 2 pa tients with schizo phre nia ex hib it ing promi nent nega tive symp toms. In all, 21 free-speech ses sions (1 hour each) were tape-recorded and tran scribed for the 2 pa tients over sev eral months, with their full con sent.
The Al ceste tech nique uses a top-down hi er ar chi cal clas si fi ca tion to model the main word-distribution pat terns oc curring in a text. This computer-assisted method makes it pos si ble to ana lyse the sub ject's ver bal be hav iour and speech pat terns at sev eral lev els si mul ta neously; we used it to ana lyse the 2 subjects' ver bal ma te rial.
Com pared with what was ob served in a pre vi ous study of sub jects with schizophre nia who ex hib ited posi tive symptoms (1,2), the 2 sub jects with schizo phre nia and promi nent nega tive symp toms pro duced a dif fer ent spe cific type of dis course. First, the fol low ing ele ments were ab sent in their speech: seman tic or syn tac tic im pair ment; language com mu ni ca tion dis tur bance; "lan guage sat el lite" traits (2); lan guage dis rup tion or lack of plan ning; and, finally, co he sion and self-monitoring. Sec ond, analy sis re vealed a pov erty of speech con tent. Third, they em ployed very sim ple, lin ear speech forms (meton ymic speech) that lacked any di gression, meta phor, or imagi nary idea. They did not sepa rate what they were do ing from what they were say ing; they seemed to be com pletely en grossed in the pres ent re al ity, pos si bly due to some lack of imagi nary or sym bolic rep re senta tive abil ity. Fourth, analy sis of the under ly ing syn tac tic pro cesses showed that the 2 pa tients seemed to ex hibit a mini mum sense of iden tity that was based on their own pa thol ogy and the sur round ing world, in clud ing medi cal treat ment. The find ing that a pos si ble sense of iden tity was re flected in the discourse of a pa tient with schizo phre nia is very im por tant, be cause no such char acter is tic was ob served in the speech of a pa tient with schizo phre nia and
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Let ters to the Editor de lu sions in a pre vi ous study (1, 2) . This sug gests that the mini mum sense of iden tity pro duced by the dis ease it self en ables pa tients to avoid suc cumb ing to de lu sional psy cho sis. The ver bal be haviour of pa tients with schizo phre nia and promi nent posi tive or nega tive symptoms dif fers, re flect ing the dif fer ences be tween the un der ly ing men tal dis orders in volved. These 2 groups need to be dealt with sepa rately in in ves ti ga tions on schizo phrenic lan guage, which has not been the case un til now. 
Electroconvulsive Therapy in Cases of Treatment-Resistant Psychosis
Dear Edi tor:
Evi dence sup ports the role of elec trocon vul sive ther apy (ECT) as an augmen ta tion strat egy in treat ing re frac tory schizo phre nia or schi zoaf fec tive dis order (1) . Stud ies that have iden ti fied a treatment-resistant popu la tion, or employed ECT aug men ta tion with clo zapine, have re ported global im prove ment (2-13); how ever, few in ves ti ga tions have fo cused on changes in spe cific symp toms (14-16). To this end, we followed the re sponse to ECT among various clini cal di men sions in a small group with treatment-resistant schi zoaf fec tive dis or der.
Based on treat ment re sis tance, 4 subjects with schi zoaf fec tive dis or der were re ferred for ECT aug men ta tion. They were tested with the Brief Psy chi at ric Rat ing Scale (BPRS) (17) and the Calgary De pres sion Scale (CDS) (18) at base line and 1 month post-ECT. In all cases, ECT was bi lat eral. The number of treat ments ranged from 5 to 13.
On the BPRS, to tal score mean im provement was 29.5%. For the subscales, it was as fol lows: think ing dis or der, 21.5%; with drawal or re tar da tion, 31.5%; anx ious de pres sion, 33.8%; hostil ity or sus pi cious ness, 11.8%; and ac tiva tion, 31.5%. CDS mean im prove ment was 5.5%.
Treat ment re sis tance to an tipsy chotic ther apy is as high as 25% in pa tients with schizo phre nia or schi zoaf fec tive dis order (19). As many as 40% to 70% of these pa tients fail to de rive sig nifi cant clini cal bene fit from a trial of clo zap ine (20). It is there fore not sur pris ing that aug men ta tion ap proaches, in clud ing ECT, are pur sued.
Re ports gen er ally sup port a global improve ment in symp toms when ECT is used as an aug men ta tion strat egy. Pharma cologic tri als car ried out in re frac tory pa tients of ten iden tify a 20% im provement as evi dence of re sponse, and the find ings of our re port, as well as oth ers, sug gest that this de gree of im prove ment is not un rea son able fol low ing ECT (9, (11) (12) (13) (14) (15) (16) .
The mean im prove ment of only 11.8% on the hos til ity or sus pi cious ness subscale may re flect the rela tively low base line scores; in 1 sub ject with a higher base line score, im prove ment exceeded 50%. CDS mean im prove ment was only 5.5%, which was at trib uted to 1 sub ject with marked wors en ing on this meas ure at end point. Over all, the findings here are com pati ble with other reports not ing that im prove ment is not con fined to posi tive or af fec tive symptoms (9, 15, 16) .
Al though not meas ured for mally, we did not iden tify any ad verse events in the 4 sub jects as a re sult of add ing ECT to antipsy chotic ther apy. In gen eral, it appears that com bined ECT and an tipsy chotic treat ment is safe and effec tive (1, 10, 16, 21) .
Re sponse du ra tion is a more trou blesome con cern. It is a com mon be lief that the bene fits of ECT use in an ill ness like schizo phre nia are rela tively short-lived, re quir ing on go ing main te nance treatment (1). When we re evalu ated 2 of the 4 sub jects at 3 months post-ECT, 1 sub ject with a base line to tal BPRS of 63 recorded a 46% im prove ment at month 1 and 38% at month 3. An other re corded a base line to tal BPRS of 35, with a 14% im prove ment at month 1 but 11% de terio ra tion at month 3.
Our re sults sug gest that ECT can be a use ful aug men ta tion ap proach in cases of re frac tory psy cho sis and that the improve ment can be seen across sev eral clini cal meas ures. How long this response is main tained is not clear, however, nor are the fac tors that might re flect an in creased risk of re lapse follow ing ECT dis con tinua tion.
